James B Breitmeyer - Net Worth and Insider Trading
James B Breitmeyer Net Worth
The estimated net worth of James B Breitmeyer is at least $61,870 dollars as of 2024-11-29. James B Breitmeyer is the Director of Zogenix Inc and owns about 1,250 shares of Zogenix Inc (ZGNX) stock worth over $33,350. James B Breitmeyer is also the CEO of Oncternal Therapeutics Inc and owns about 38,159 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $28,520. Details can be seen in James B Breitmeyer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James B Breitmeyer has not made any transactions after 2023-04-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James B Breitmeyer
James B Breitmeyer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James B Breitmeyer owns 3 companies in total, including Otonomy Inc (OTIC) , Zogenix Inc (ZGNX) , and Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of James B Breitmeyer’s form 4 insider trades.
Insider Ownership Summary of James B Breitmeyer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTIC | Otonomy Inc | 2018-06-19 | director |
| ZGNX | Zogenix Inc | 2020-05-29 | director |
| ONCT | Oncternal Therapeutics Inc | 2023-04-14 | director & President & CEO |
James B Breitmeyer Latest Holdings Summary
James B Breitmeyer currently owns a total of 2 stocks. Among these stocks, James B Breitmeyer owns 1,250 shares of Zogenix Inc (ZGNX) as of December 16, 2019, with a value of $33,350 and a weighting of 53.9%. James B Breitmeyer also owns 38,159 shares of Oncternal Therapeutics Inc (ONCT) as of April 14, 2023, with a value of $28,520 and a weighting of 46.1%.
Latest Holdings of James B Breitmeyer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZGNX | Zogenix Inc | 2019-12-16 | 1,250 | 26.68 | 33,350 |
| ONCT | Oncternal Therapeutics Inc | 2023-04-14 | 38,159 | 0.75 | 28,520 |
Holding Weightings of James B Breitmeyer
James B Breitmeyer Form 4 Trading Tracker
According to the SEC Form 4 filings, James B Breitmeyer has made a total of 1 transactions in Zogenix Inc (ZGNX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zogenix Inc is the sale of 5,000 shares on December 16, 2019, which brought James B Breitmeyer around $250,000.
According to the SEC Form 4 filings, James B Breitmeyer has made a total of 2 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 7,500 shares on April 14, 2023, which cost James B Breitmeyer around $43,500.
Insider Trading History of James B Breitmeyer
- 1
James B Breitmeyer Trading Performance
GuruFocus tracks the stock performance after each of James B Breitmeyer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James B Breitmeyer is -0.27%. GuruFocus also compares James B Breitmeyer's trading performance to market benchmark return within the same time period. The performance of stocks bought by James B Breitmeyer within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James B Breitmeyer's insider trading performs compared to the benchmark.
Performance of James B Breitmeyer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.18 | | | | | |
| Relative Return to S&P 500(%) | 0.68 | | | | | |
James B Breitmeyer Ownership Network
James B Breitmeyer Owned Company Details
What does Otonomy Inc do?
Who are the key executives at Otonomy Inc?
James B Breitmeyer is the director of Otonomy Inc. Other key executives at Otonomy Inc include Chief Scientific Officer Alan Charles Foster , director & President & CEO David Allen Weber , and CFO/Ch. Business Offcr & Sec. Paul E Cayer .
Otonomy Inc (OTIC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Otonomy Inc (OTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Otonomy Inc (OTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Otonomy Inc (OTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Otonomy Inc Insider Transactions
James B Breitmeyer Mailing Address
Above is the net worth, insider trading, and ownership report for James B Breitmeyer. Currently GuruFocus does not have mailing address information for James B Breitmeyer.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
